MedPath

Preventive effect of Sivelestat Na Hydrate on postoperative acute exacerbation of idiopathic interstitial pneumonia in the patient with lung cancer

Phase 3
Conditions
idiopathic interstitial pneumonia (IIP)
Registration Number
JPRN-UMIN000021109
Lead Sponsor
Japanese Northern East Area Thoracic Surgery Study Group (JNETS)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Not provided

Exclusion Criteria

(1) With serious liver disorder (2) With serious renal dysfunction (3) With bleeding tentency (4) Patients registered in clinical trial of other drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
acute exacerbation of IIP within 30 postoperative days
Secondary Outcome Measures
NameTimeMethod
30 postoperative day survival rate
© Copyright 2025. All Rights Reserved by MedPath